Xytronyx reported a $465,241 net loss for...

Xytronyx reported a $465,241 net loss for the first quarter ended June 30. The San Diego-based biotechnology company reported a $466,432 net loss during the previous first quarter. Revenue, consisting solely of interest income, fell slightly to $13,595, down from $14,032 during the previous first quarter.

During the first quarter, Xytronyx completed a private placement of preferred convertible stock that yielded net proceeds of $2.35 million. Xytronyx is developing biotechnology products for medicine, veterinary medicine and dentistry markets.